Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement
出版年份 2013 全文链接
标题
Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement
作者
关键词
Alzheimer’s disease, AD, MCI, prodromal, asymptomatic, amyloid cascade hypothesis, amyloid-beta, tau, biomarkers, theragnostic biomarkers, target engagement, mechanism of action, pathophysiological mechanisms, neurobiochemical markers, CSF, blood, early detection, disease-modifying compounds, therapy, clinical trials, prevention trials
出版物
Journal of Nutrition Health & Aging
Volume 17, Issue 1, Pages 54-63
出版商
Springer Nature
发表日期
2013-01-09
DOI
10.1007/s12603-013-0003-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
- (2017) Ashley I. Bush JOURNAL OF ALZHEIMERS DISEASE
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Non-Steroidal Anti-Inflammatory Drugs and Alzheimers Disease: The Epidemiological Evidence
- (2012) C.A. Szekely et al. CNS & Neurological Disorders-Drug Targets
- PRINT - ALZHEIMER’S
- (2012) Meredith Wadman NATURE
- Sting of Alzheimer's failures offset by upcoming prevention trials
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- From inherited to sporadic AD—crossing the biomarker bridge
- (2012) Harald Hampel et al. Nature Reviews Neurology
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stopping Alzheimer's Before It Starts
- (2012) G. Miller SCIENCE
- Preventing Alzheimer's Disease
- (2012) D. J. Selkoe SCIENCE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception
- (2011) Michael W. Weiner et al. Alzheimers & Dementia
- Evidence for Ordering of Alzheimer Disease Biomarkers
- (2011) Clifford R. Jack ARCHIVES OF NEUROLOGY
- Diagnosis and biomarkers of predementia in Alzheimer's disease
- (2011) Orestes V Forlenza et al. BMC Medicine
- A Blood-Based Algorithm for the Detection of Alzheimer’s Disease
- (2011) Sid E. O’Bryant et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
- (2011) Hong Jiang et al. Molecular Neurodegeneration
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
- (2011) Rebecca Craig-Schapiro et al. PLoS One
- Prevention trials in Alzheimer's disease: An EU-US task force report
- (2011) Bruno Vellas et al. PROGRESS IN NEUROBIOLOGY
- Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
- (2011) Michael Ewers et al. TRENDS IN NEUROSCIENCES
- Disease-modifying treatments for Alzheimer’s disease
- (2011) Daniela Galimberti et al. Therapeutic Advances in Neurological Disorders
- Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors
- (2010) K. Blennow et al. ACTA NEUROLOGICA SCANDINAVICA
- A Serum Protein–Based Algorithm for the Detection of Alzheimer Disease
- (2010) Sid E. O’Bryant ARCHIVES OF NEUROLOGY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Low Incidence of Post-Lumbar Puncture Headache in 1,089 Consecutive Memory Clinic Patients
- (2010) Henrik Zetterberg et al. EUROPEAN NEUROLOGY
- High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
- (2010) Hiroaki Fukumoto et al. FASEB JOURNAL
- Prediction of Alzheimer’s Disease Using Midregional Proadrenomedullin and Midregional Proatrial Natriuretic Peptide
- (2010) Katharina Buerger et al. JOURNAL OF CLINICAL PSYCHIATRY
- Reimagining Alzheimer's Disease--An Age-Based Hypothesis
- (2010) K. Herrup JOURNAL OF NEUROSCIENCE
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Biomarkers in Alzheimer's disease drug development
- (2010) Kaj Blennow NATURE MEDICINE
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biomarkers for Alzheimer's disease therapeutic trials
- (2010) Harald Hampel et al. PROGRESS IN NEUROBIOLOGY
- Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
- (2010) Henrik Zetterberg et al. Alzheimers Research & Therapy
- A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
- (2010) Erik Portelius et al. Alzheimers Research & Therapy
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Blood-Based Microcirculation Markers in Alzheimer's Disease–Diagnostic Value of Midregional Pro-atrial Natriuretic Peptide/C-terminal Endothelin-1 Precursor Fragment Ratio
- (2009) Katharina Buerger et al. BIOLOGICAL PSYCHIATRY
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
- (2009) Clifford R. Jack et al. BRAIN
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- Biological markers of amyloid β-related mechanisms in Alzheimer's disease
- (2009) Harald Hampel et al. EXPERIMENTAL NEUROLOGY
- Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
- (2009) Kajsa Sämgård et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Update on amyloid‐βhomeostasis markers for sporadic Alzheimer's disease
- (2009) Henrik Zetterberg SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
- (2008) Ahmadul Kadir et al. ANNALS OF NEUROLOGY
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- First Demonstration of Cerebrospinal Fluid and Plasma A Lowering with Oral Administration of a -Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates
- (2008) S. Sankaranarayanan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
- Beta‐site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease
- (2008) Harald Hampel et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease
- (2007) Harald Hampel et al. Alzheimers & Dementia
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started